Factors associated with radiation therapy incompletion for patients with early-stage breast cancer

被引:11
|
作者
Freedman, Rachel A. [1 ]
Fedewa, Stacey A. [2 ]
Punglia, Rinaa S. [1 ]
Lin, Chun Chieh [2 ]
Ward, Elizabeth M. [2 ]
Jemal, Ahmedin [2 ]
Sineshaw, Helmneh M. [2 ]
机构
[1] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
[2] Amer Canc Soc, 250 Williams St NW, Atlanta, GA 30303 USA
关键词
Breast cancer; Radiation; Incomplete treatment; LUMPECTOMY PLUS TAMOXIFEN; ADJUVANT TRASTUZUMAB; LOCAL THERAPY; OLDER WOMEN; MASTECTOMY; AGE; RADIOTHERAPY; IRRADIATION; SURGERY; DELAY;
D O I
10.1007/s10549-015-3660-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The purpose of the study was to examine factors associated with adjuvant radiation treatment (RT) incompletion for women with breast cancer within a large national cancer database. Methods We identified 394,334 women diagnosed with stage I III breast cancer during 2004-2012 in the national cancer database who initiated adjuvant external beam adjuvant RT and examined the proportion of women not completing treatment. We used multivariable logistic regression to examine patient, clinical, and facility factors associated with RT incompletion for those who had breast conserving surgery (BCS), defined as <15 fractions and <3990 centiGray [cGy] (accounting for adoption of hypofractionation), and mastectomy (PMRT, defined as <5000 cGy and <25 fractions), separately. We also examined RT incompletion after BCS using more traditional definitions of <25 fractions and <4500 cGy for diagnosis years <2010. Results Among the 319,003 women who underwent BCS and the 75,331 women who underwent mastectomy and initiated RT, 98.4 and 97.8 % completed radiation, respectively. In adjusted analyses, older age was associated with RT incompletion (odds ratio [O.R.] for age >= 80 = 2.53 for BCS-treated, 95 % confidence interval [CI] 2.19-2.92; O.R. for PMRT incompletion = 2.33, 95 % CI 1.84-2.96; both versus age <50). In addition, those with >2 comorbidities and lower -risk disease had higher odds of RT incompletion. After defining RT completion using more traditional definitions, 94.0 % completed treatment. Conclusions Reassuringly, we found a very low proportion of patients not completing RT, though we observed a higher likelihood for treatment incompletion in some subgroups, most notably older women. Further studies should focus on reasons for treatment discontinuation in populations at risk for suboptimal treatment.
引用
收藏
页码:187 / 199
页数:13
相关论文
共 50 条
  • [21] Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer
    Orecchia, R
    Ciocca, M
    Lazzari, R
    Garibaldi, C
    Leonardi, MC
    Luini, A
    Intra, M
    Gatti, G
    Veronesi, P
    Petit, JI
    Veronesi, U
    BREAST, 2003, 12 (06): : 483 - 490
  • [22] Partial breast radiation for early-stage breast cancer
    McCormick, Beryl
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (01) : 31 - 37
  • [23] FACTORS ASSOCIATED WITH EARLY-STAGE BREAST CANCER PATIENTS' CONCERNS ABOUT RISK OF RECURRENCE
    Jeffe, Donna B.
    Myles, Stephanie L.
    Perez, Maria
    Queen, Erica
    Massman, Kerry L.
    Schootman, Mario
    Gillanders, William E.
    Aft, Rebecca L.
    ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S142 - S142
  • [24] The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer
    Boero, Isabel J.
    Gillespie, Erin F.
    Hou, Jiayi
    Paravati, Anthony J.
    Kim, Ellen
    Einck, John P.
    Yashar, Catheryn
    Mell, Loren K.
    Murphy, James D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 571 - 580
  • [25] Socioeconomic Factors Impact Probability of Receiving Radiation As Part of Breast Conserving Therapy for Early-Stage Breast Cancer
    Sura, K.
    Ye, H.
    Grills, I. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E18 - E18
  • [26] Factors associated with surgical and radiation therapy for early stage breast cancer in older women
    BallardBarbash, R
    Potosky, AL
    Harlan, LC
    Nayfield, SG
    Kessler, LG
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (11): : 716 - 726
  • [27] Prospective Evaluation of Normal Tissue Toxicity Associated With Breast Boost in Early-Stage Breast Cancer Radiation Therapy
    Lee, G.
    Lalani, N.
    Emad, N.
    Gill, B.
    Panzarella, T.
    Koch, C. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E27 - E28
  • [28] Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients
    Schroen, AT
    Brenin, DR
    Kelly, MD
    Knaus, WA
    Slingluff, CL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7074 - 7080
  • [29] Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery
    Buchholz, Thomas A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (01): : 63 - 70
  • [30] Neoadjuvant therapy in early-stage breast cancer
    Moreno-Aspitia, Alvaro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 (02) : 187 - 199